Emin Yener GÜLTEKİN, Esin YILDIZ, Semih AYAN, Esat KORĞALI, Hüseyin SAYGIN, Ziynet ÇINAR, Gökhan GÖKÇE

Is renal cell cancer stage migration valid throughout the world?

To investigate changes in tumor sizes and pathological tumor stages in patients undergoing surgery for renal mass between 2000 and 2011. Materials and methods: The data of 157 patients who underwent surgery for renal mass, including TNM stage, size, and Fuhrman grade at final pathology, were evaluated retrospectively. Results: The mean pathological size of the tumor in the whole population of the study was 6.97 cm. The mean size of the renal mass was 7.22 cm, 7.05 cm, and 6.91 cm in group 1, group 2, and group 3, respectively, and the difference was not statistically significant. Of the renal cell carcinomas, 57.2% were stage I, 22.7% were stage II, 10.3% were stage III, and 9.6% were stage IV. Differences between groups in terms of changes in tumor stage were not statistically significant. Conclusion: We observed that there was no downward stage migration in renal cell carcinoma during the 12-year study period.

Anahtar Kelimeler:

Key words: Renal cell carcinoma, stage migration, histology, grade

Is renal cell cancer stage migration valid throughout the world?

Keywords:

Key words: Renal cell carcinoma, stage migration, histology, grade,

PDF

___

Parkin DM, Bray F, Ferlay J., Pisani P. Global cancer statistics, 200 CA Cancer J Clin 2005; 55: 74–108.
Gudbjartsson T, Hardarson S, Petursdottir V, Thoroddsen A, Magnusson J, Einarsson GV. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol 2005; 48: 593–600.
Tanagho EA, McAninch JW. Smith’s General Urology, 16th edn. New York: Lange Medical Books/McGraw-Hill; 2004.
Decastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin North Am 2008; 35: 581–92.
Akbulut Z, Tuzlalı M, Canda AE, Ercan K, Kandemir O, Balbay MD. Factors affecting adrenal gland involvement in patients who underwent radical nephrectomy for renal cell carcinoma. Turk J Med Sci 2009; 39: 215–22.
Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma—age and stage characterization and clinical implications: study of 1092 patients. Urology 2000; 56: 58–62.
Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008; 113: 78–83.
Pichler M, Hutterer GC, Chromecki TF, Jesche J, KampelKettner K, Pummer K et al. Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival. Int Urol Nephrol 2012; 44: 997–1004.
Doeuk N, Guo DY, Haddad R, Lau H, Woo HH, Bariol S et al. Renal cell carcinoma: stage, grade and histology migration over the last 15 years in a large Australian surgical series. BJU Int 2011; 107: 1381–5.
Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004. 11 Jacqmin D, van Poppel H, Kirkali Z, Mickisch G. Renal cancer. Eur Urol 2001; 39: 361–9.
Glassman D, Chawla SN, Waldman I, Johannes J, Byrne DS, Trabulsi EJ et al. Correlation of pathology with tumor size of renal masses. Can J Urol 2007; 14: 3616–20.
Schachter LR, Cookson MS, Chang SS, Smith JA Jr, Dietrich MS, Jayaram G et al. Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients. J Endourol 2007; 21: 819–23.
Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003; 170: 2217–20.